Potential Drug Targets For Early Onset Glaucoma, Georgia Institute of Technology Study

Published: Jan 24, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Using a novel high-throughput screening process, scientists have for the first time identified molecules with the potential to block the accumulation of a toxic eye protein that can lead to early onset of glaucoma. Glaucoma is a group of diseases that can damage the eye’s optic nerve and cause vision loss and blindness. Elevated eye pressure is the main risk factor for optic nerve damage.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news